HIV-1 latency reversal agent boosting is not limited by opioid use
Tyler J. Lilie(Brigham and Women's Hospital), Athe Tsibris(Brigham and Women's Hospital)
Cited by 2
Related Papers
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
|PLoS ONE|2009|233
SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality
|Research Square|2020|51